- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06249815
Sequential Use of Foley's Catheter and Misoprostol Versus Misoprostol Alone for Induction of Labour: a Multicentre Randomised Controlled Trial
March 13, 2024 updated by: Dilfuza Sultanmuratova, Kazakhstan's Medical University "KSPH"
Sequential Use of Foley's Catheter and Low Dose Oral Misoprostol Versus Misoprostol Alone for Induction of Labour : a Multicentre Randomised Controlled Trial
Evaluation of efficacy of inducing labour using a Foley's catheter and low dose oral misoprostol sequentially, in comparison with low dose oral misoprostol alone.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
a multicentre, open-label randomised controlled trial in 2 hospitals in the Almaty,Kazakhstan.
Women with a term singleton pregnancy in cephalic presentation, an unfavourable cervix, intact membranes, and without a previous caesarean section will be randomly allocated to 2 groups: 1 group -cervical ripening with Foley's catheter for 16 hour and sequentially 25 μg oral misoprostol once every 2 hour, 2 nd group- 25 μg oral misoprostol once every 2 hour.
The primary outcome will be vaginal delivery within 24 hours(to evaluate effectiveness) and secondary outcoms 1-5-min Apgar score and hospitalization in ICU, rate of hyperstimulation ,hemorrage,chorioamnionitis (for evaluating safety)
Study Type
Interventional
Enrollment (Estimated)
400
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: DILFUZA SULTANMURATOVA
- Phone Number: +77787420209
- Email: sultanmuratova.dd@Gmail.com
Study Locations
-
-
-
Almaty, Kazakhstan, A15H0K1
- Center for Perinatology and Pediatric Cardiac Surgery
-
Almaty, Kazakhstan, 050062
- City Perinatology Centre 3
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- women with an unfavourable cervix who will scheduled for induction of labour
Exclusion Criteria:
- Women with previous caesarean sections unable to give informed consent Multiple pregnancy History of allergy to misoprostol Ruptured membranes All cases when physiological childbirth is impossible (placenta previa,transverse position of the fetus )
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Foley catheter + misoprostol
-cervical ripening with transcervical Foley catheter 22 F for 16 hours, then sequentially 25 μg oral misoprostol once every 2 hour.Max 200 μg
|
ranscervical Foley catheter (silicone, size 20F with 30ml balloon)+Misoprostol 200 mcg dissolvedwith 200 ml water and divided to 25ml solution every 2 hours per os for maximum of 8 doses
Other Names:
|
Active Comparator: misoprostol
25 μg oral misoprostol alone once every 2 hour, Max 200 μg.
|
Misoprostol 200 mcg dissolvedwith 200 ml water and divided to 25ml solution every 2 hours per os for maximum of 8 doses
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Efficiency of induction
Time Frame: 24 hours.
|
Number of Participants with vaginal births
|
24 hours.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Safety for baby
Time Frame: 5 minutes
|
Rate of cases Apgar score <7 points
|
5 minutes
|
Safety for mother
Time Frame: 24 hour
|
incidence of hyperstimulation
|
24 hour
|
rete of hemorrage
Time Frame: 24 hour
|
bleeding more than 500 ml during the vaginal delivery, more than 1000 ml after c-section
|
24 hour
|
rate of chorioamnionitis chorioamnionitis
Time Frame: 24 hour
|
meconial amniotic fluid, tachycardia, leukocytosis
|
24 hour
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
March 15, 2024
Primary Completion (Estimated)
December 31, 2024
Study Completion (Estimated)
December 31, 2024
Study Registration Dates
First Submitted
January 12, 2024
First Submitted That Met QC Criteria
February 6, 2024
First Posted (Actual)
February 8, 2024
Study Record Updates
Last Update Posted (Actual)
March 15, 2024
Last Update Submitted That Met QC Criteria
March 13, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB-23-2024
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Induction of Labor
-
Rambam Health Care CampusNot yet recruitingInduction of Labor
-
Duke UniversityCompleted
-
Ochsner Health SystemNorthwell HealthTerminatedInduction of LaborUnited States
-
Brigham and Women's HospitalCompleted
-
Aultman Health FoundationCompletedInduction of LaborUnited States
-
Dina Yahia MansourUnknown
-
HaEmek Medical Center, IsraelCompletedSingle Balloon Catheter Compared With Double Balloon Catheter for Ripening of the Unfavorable CervixInduction of LaborIsrael
-
Tel-Aviv Sourasky Medical CenterUnknown
-
Holy Family Hospital, Nazareth, IsraelRecruitingInduction of LaborIsrael
-
Kazakhstan's Medical University "KSPH"Asfendiyarov Kazakh National Medical UniversityActive, not recruitingInduction of LaborKazakhstan
Clinical Trials on Misoprostol 200mcg Tab
-
Hospital de Clinicas de Porto AlegreCompletedMiscarriage in First TrimesterBrazil
-
Professor Fernando Figueira Integral Medicine InstituteCompleted
-
Rajavithi HospitalCompletedInfertility, Female | Chronic Pelvic Pain | Abnormal Uterine BleedingThailand
-
Assuta Ashdod HospitalRecruitingRetained Products of ConceptionIsrael
-
Ain Shams Maternity HospitalActive, not recruitingInduction of Labor | Transvaginal Ultrasound: Cervical Sliding SignEgypt
-
Cairo UniversityRecruitingMisoprostol AllergyEgypt
-
Kazakhstan's Medical University "KSPH"Asfendiyarov Kazakh National Medical UniversityActive, not recruitingInduction of LaborKazakhstan
-
Cairo UniversityRecruiting